The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation
Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common
complications affecting solid organ transplant recipients, conveying higher risks of …
complications affecting solid organ transplant recipients, conveying higher risks of …
[HTML][HTML] Cytomegalovirus infection in transplant recipients
Cytomegalovirus infection is a frequent complication after transplantation. This infection
occurs due to transmission from the transplanted organ, due to reactivation of latent …
occurs due to transmission from the transplanted organ, due to reactivation of latent …
Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation
Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ
transplantation, resulting in significant morbidity, graft loss, and adverse outcomes …
transplantation, resulting in significant morbidity, graft loss, and adverse outcomes …
[HTML][HTML] The impact of infection on chronic allograft dysfunction and allograft survival after solid organ transplantation
C Martin-Gandul, NJ Mueller, M Pascual… - American Journal of …, 2015 - Elsevier
Infectious diseases after solid organ transplantation (SOT) are a significant cause of
morbidity and reduced allograft and patient survival; however, the influence of infection on …
morbidity and reduced allograft and patient survival; however, the influence of infection on …
[HTML][HTML] Recent advancement in nanotechnology-based drug delivery system against viral infections
In the last few decades, the exponential rise in the incidence of viral infections sets a global
health emergency across the world. The biomimetic architecture, the ability to hijack host …
health emergency across the world. The biomimetic architecture, the ability to hijack host …
[HTML][HTML] Pretransplant immediately early-1-specific T cell responses provide protection for CMV infection after kidney transplantation
O Bestard, M Lucia, E Crespo, B Van Liempt… - American Journal of …, 2013 - Elsevier
Cytomegalovirus (CMV) infection is still a major complication after kidney transplantation.
Although cytotoxic CMV-specific T cells play a crucial role controlling CMV survival and …
Although cytotoxic CMV-specific T cells play a crucial role controlling CMV survival and …
Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
DS Owers, AC Webster, GFM Strippoli… - Cochrane database …, 2013 - cochranelibrary.com
Background Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in solid
organ transplant recipients. Pre‐emptive treatment of patients with CMV viraemia using …
organ transplant recipients. Pre‐emptive treatment of patients with CMV viraemia using …
[HTML][HTML] Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients
O Manuel, G Kralidis, NJ Mueller, HH Hirsch… - American journal of …, 2013 - Elsevier
We assessed the impact of antiviral prophylaxis and preemptive therapy on the incidence
and outcomes of cytomegalovirus (CMV) disease in a nationwide prospective cohort of solid …
and outcomes of cytomegalovirus (CMV) disease in a nationwide prospective cohort of solid …
Canadian Cardiovascular Society/Canadian Cardiac Transplant Network position statement on heart transplantation: patient eligibility, selection, and post …
S Chih, M McDonald, A Dipchand, D Kim… - Canadian Journal of …, 2020 - Elsevier
Significant practice-changing developments have occurred in the care of heart
transplantation candidates and recipients over the past decade. This Canadian …
transplantation candidates and recipients over the past decade. This Canadian …
[HTML][HTML] Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: long-term results after 7 years of a randomized …
O Witzke, M Nitschke, M Bartels, H Wolters… - …, 2018 - journals.lww.com
Background The VIPP study compared valganciclovir prophylaxis with preemptive treatment
regarding efficacy, safety, and long-term graft outcome in cytomegalovirus (CMV)-positive …
regarding efficacy, safety, and long-term graft outcome in cytomegalovirus (CMV)-positive …